Clinical Diagnostics

A Chelsea and Westminster pilot used ThinkSono AI with handheld ultrasound to halve DVT wait times and enable sub-30-minute clinical decisions.

A concise look at how AI improves diagnostic accuracy, speeds early detection, and what health systems must address for safe, equitable adoption.

A concise update on AI diagnostics: current applications in radiology, pathology, ophthalmology and cardiology, recent approvals, clinical impact and near-term outlook.

FDA clears a combined AI and fundus imaging solution—iHealthScreen’s iPredict-DR with Revenio’s iCare DRSplus—for diabetic retinopathy screening in primary care, widening access to early detection.

How AI governance is shaping safe, fair diagnostic AI — market growth, key safeguards, generative AI risks, and the firms building compliant solutions.

How MDR/IVDR and the EU AI Act collide for AI diagnostics, the risks for startups and patients, and practical remedies like sandboxes and a least-burdensome approach.

A concise overview of AI in medical diagnostics: imaging, clinical decision support, ethics, HIPAA, FDA, EU AI Act, human oversight, and future trends.

Helsinki-based Aiforia receives €20 million from the EIB to advance CE-IVD AI pathology tools, speeding digital tissue analysis and strengthening European health tech leadership.

How agentic AI can scale specialist-level diagnosis and care for Alzheimer’s and dementia via multimodal data, decision support, continuous learning, and ethical safeguards.

July 2026 roundup of AI in diagnostics: key advances in radiology, pathology, predictive analytics, clinical impact and near-term outlook for clinicians.